Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 17, Issue 16, pp. 5275-5286
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 14, 2010
- Revision received June 7, 2011
- Accepted June 13, 2011
- Published first June 28, 2011.
Article Versions
- Previous version (June 28, 2011 - 08:46).
- Previous version (August 9, 2011 - 09:32).
- You are viewing the most recent version of this article.
Copyright & Usage
©2011 American Association for Cancer Research.
Author Information
- Rachel Sharpe1,
- Alex Pearson1,
- Maria T. Herrera-Abreu1,
- Damian Johnson1,
- Alan Mackay1,
- Jonathan C. Welti1,
- Rachael Natrajan1,
- Andrew R. Reynolds1,
- Jorge S. Reis-Filho1,
- Alan Ashworth1, and
- Nicholas C. Turner1,2
- Authors' Affiliations: 1The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research; and 2Breast Unit, Royal Marsden Hospital, London, United Kingdom
- Corresponding Author:
Nicholas C. Turner, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom. Phone: 44-207-1535574; Fax: 44-0-207-51535340; E-mail: nicholas.turner{at}icr.ac.uk
R. Sharpe and A. Pearson have contributed equally to this work.
August 2011
Volume 17, Issue 16
Volume 17, Issue 16
FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo
Jump to section
Advertisement